This panel of iconic healthcare and life sciences investors will share their perspectives on top areas for AI and digital health investment. Recent reports show that the number of AI deals in healthcare has grown at twice the rate of AI deals across the tech sector, and one in four dollars invested in healthcare going toward companies leveraging AI. In particular, areas such as patient engagement, clinical decision support, and AI tools for drug discovery and preventative monitoring have shown significant investment traction. Join this panel of seasoned investors who will share what factors are driving early- and late-stage investment decisions, as well as how best to position your company for success given the current market dynamics.